U.S., Nov. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07249294) titled 'Program to Avoid NSAIDs in Patients With Advanced Chronic Liver Disease' on Nov. 18.
Brief Summary: This study aims to implement measures to avoid the use of NSAIDs or metamizole in patients with advanced chronic liver disease (ACLD) scheduled for major surgery, which are contraindicated due to increased risk of renal dysfunction such as acute kidney injury (AKI), clinical decompensation such as ascites, and bleeding.
Study Start Date: April 01, 2023
Study Type: INTERVENTIONAL
Condition:
Advanced Chronic Liver Disease
Portal Hypertension Related to Cirrhosis
Intervention:
BEHAVIORAL: Multidisciplinary support program
The inte...